These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 3631977

  • 1. [Introduction of natural interferon-alpha "Sumiferon"].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2800-3. PubMed ID: 3631977
    [Abstract] [Full Text] [Related]

  • 2. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K.
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [Abstract] [Full Text] [Related]

  • 3. [Effects of interferon on various malignancies].
    Taguchi T.
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
    [Abstract] [Full Text] [Related]

  • 4. [Clinical trial of human lymphoblastoid interferon on advanced malignancy].
    Usui N, Ogawa M, Inagaki J, Horikoshi N, Inoue K, Miyamoto H, Ikeda K, Nakada H, Adachi K, Okada Y.
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2324-9. PubMed ID: 6357102
    [Abstract] [Full Text] [Related]

  • 5. [Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma].
    Yoshida M, Ohta M, Muroi K, Takeda K, Kitagawa S, Tsuboyama A, Sakamoto S, Miura Y, Mutoh Y.
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1394-8. PubMed ID: 6742866
    [Abstract] [Full Text] [Related]

  • 6. [Clinical study on the effect of human lymphoblastoid interferon in multiple myeloma].
    Takeyama H, Yano K, Kataoka T, Yamamoto M, Emi N, Kodera Y, Kawashima K, Ohno R, Yokomaku S, Kobayashi M.
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2043-8. PubMed ID: 6614939
    [Abstract] [Full Text] [Related]

  • 7. [Phase II study of recombinant human interferon gamma (S-6810) in renal cell carcinoma. Urological Cooperative Study Group of Recombinant Human Interferon Gamma (S-6810)].
    Machida T, Koiso K, Takaku F, Ogawa M.
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):440-5. PubMed ID: 3101607
    [Abstract] [Full Text] [Related]

  • 8. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 Feb; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 9. [Therapy of renal cell carcinoma. 3. Interferon therapy].
    Kobayashi M, Imai K, Kiren H, Nakai K, Saruki K, Umeyama T, Ito Y, Yamanaka H, Makino T, Machida M.
    Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
    [Abstract] [Full Text] [Related]

  • 10. [Clinical study on the effect of natural alpha-interferon (HLBI) in the treatment of adult T-cell leukemia].
    Ichimaru M, Kamihira S, Moriuchi Y, Kuraishi Y, Usui N, Toki H, Okabe K, Niho Y, Shibuya T, Umei T.
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2975-81. PubMed ID: 3052302
    [Abstract] [Full Text] [Related]

  • 11. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
    [Abstract] [Full Text] [Related]

  • 12. Interferon-alpha therapy of renal cancer.
    Neidhart JA, Gagen MM, Young D, Tuttle R, Melink TJ, Ziccarrelli A, Kisner D.
    Cancer Res; 1984 Sep; 44(9):4140-3. PubMed ID: 6378379
    [Abstract] [Full Text] [Related]

  • 13. [The therapy of renal cell carcinoma with human lymphoblastoid interferon].
    Masuda F, Suzuki M, Ikemoto I, Yamazaki H, Machida T.
    Hinyokika Kiyo; 1984 May; 30(5):615-9. PubMed ID: 6206703
    [Abstract] [Full Text] [Related]

  • 14. [Sequential combination therapy with alpha interferon and OK-432 (streptococcal preparation) against advanced renal cell carcinoma].
    Marumo K, Mura M, Deguchi N, Baba S, Jitsukawa S, Nakazono M, Tazaki H.
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2434-9. PubMed ID: 3729498
    [Abstract] [Full Text] [Related]

  • 15. [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms].
    Oda Y, Irie S, Inagaki M, Fukumoto M, Ueda I, Ohmoto E, Fujimoto S, Endo Y, Watanabe S, Lai M, Takahashi I, Kimura I, Ishii H, Sezaki T.
    Gan To Kagaku Ryoho; 1983 May; 10(5):1313-9. PubMed ID: 6575725
    [Abstract] [Full Text] [Related]

  • 16. [Clinical efficacy of recombinant human leukocyte A interferon (rIFN-alpha A) on malignant tumors of the urogenital tract].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):921-7. PubMed ID: 3885863
    [Abstract] [Full Text] [Related]

  • 17. A phase II trial of high-dose human lymphoblastoid alpha interferon in patients with advanced renal carcinoma.
    Vugrin D, Hood L, Laszlo J.
    J Biol Response Mod; 1986 Aug; 5(4):309-12. PubMed ID: 3734846
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
    Kirkwood JM, Harris JE, Vera R, Sandler S, Fischer DS, Khandekar J, Ernstoff MS, Gordon L, Lutes R, Bonomi P.
    Cancer Res; 1985 Feb; 45(2):863-71. PubMed ID: 3881175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.